Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TJ088
- Development stage
- Preclinical
- Lead developer
- Tuojie Biotech
- Modality
- Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Administration
- Parenteral
01
Overview
TJ088 is a preclinical-stage small interfering RNA (siRNA) therapeutic candidate being developed by Tuojie Biotech for the treatment of tumors. As an RNA interference (RNAi) modality, TJ088 is designed to selectively silence the expression of a specific target gene that plays a critical role in tumor growth or survival. While the exact molecular target has not been publicly disclosed by the developer, the program is currently in the preclinical candidate (PCC) stage of development. Tuojie Biotech is leveraging its expertise in RNAi technology to advance TJ088 as a potential targeted therapy for oncology indications.
- Other names
- TJ088TJ-088TJ 088
Beyond the preview
Go deeper on TJ088.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TJ088.